Global Oligonucleotide Aptamer Market Growth 2024-2030

Publication ID:

LPI10249897

Publication Date:

October 14, 2024

Pages:

119

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

Oligonucleotide Aptamer are short, single-stranded nucleic acid molecules (can be RNA or DNA) that have the ability to bind to a specific target with high affinity and specificity. These aptamers are selected and developed through a method called SELEX (Systematic Evolution of Ligand Enrichment), a process that allows the screening of aptamers that can effectively recognize and bind to a variety of biomolecules, including proteins, small molecules, and cells.
The global Oligonucleotide Aptamer market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淥ligonucleotide Aptamer Industry Forecast鈥� looks at past sales and reviews total world Oligonucleotide Aptamer sales in 2023, providing a comprehensive analysis by region and market sector of projected Oligonucleotide Aptamer sales for 2024 through 2030. With Oligonucleotide Aptamer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide Aptamer industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide Aptamer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide Aptamer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Oligonucleotide Aptamer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide Aptamer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide Aptamer.
United States market for Oligonucleotide Aptamer is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Oligonucleotide Aptamer is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Oligonucleotide Aptamer is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Oligonucleotide Aptamer players cover Kaneka Corporation(Eurogentec), Danaher(Integrated DNA Technologies), Genescript, Azenta Life Sciences, Thermofischer, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide Aptamer market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
RNA Aptamers
DNA Aptamers
Segmentation by Application:
Bioanalysis and Detection
Targeted Drug Delivery
Cancer Treatment
Scientific Research
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Kaneka Corporation(Eurogentec)
Danaher(Integrated DNA Technologies)
Genescript
Azenta Life Sciences
Thermofischer
Eurofins Genomics
Merck KGaA
TriLink BioTechnologies
SBS Genetech
Bio-Synthesis Inc
Synbio Technologies
Oligo Factory
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oligonucleotide Aptamer market?
What factors are driving Oligonucleotide Aptamer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oligonucleotide Aptamer market opportunities vary by end market size?
How does Oligonucleotide Aptamer break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oligonucleotide Aptamer Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oligonucleotide Aptamer by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oligonucleotide Aptamer by Country/Region, 2019, 2023 & 2030
2.2 Oligonucleotide Aptamer Segment by Type
2.2.1 RNA Aptamers
2.2.2 DNA Aptamers
2.3 Oligonucleotide Aptamer Sales by Type
2.3.1 Global Oligonucleotide Aptamer Sales Market Share by Type (2019-2024)
2.3.2 Global Oligonucleotide Aptamer Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oligonucleotide Aptamer Sale Price by Type (2019-2024)
2.4 Oligonucleotide Aptamer Segment by Application
2.4.1 Bioanalysis and Detection
2.4.2 Targeted Drug Delivery
2.4.3 Cancer Treatment
2.4.4 Scientific Research
2.4.5 Other
2.5 Oligonucleotide Aptamer Sales by Application
2.5.1 Global Oligonucleotide Aptamer Sale Market Share by Application (2019-2024)
2.5.2 Global Oligonucleotide Aptamer Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oligonucleotide Aptamer Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Oligonucleotide Aptamer Breakdown Data by Company
3.1.1 Global Oligonucleotide Aptamer Annual Sales by Company (2019-2024)
3.1.2 Global Oligonucleotide Aptamer Sales Market Share by Company (2019-2024)
3.2 Global Oligonucleotide Aptamer Annual Revenue by Company (2019-2024)
3.2.1 Global Oligonucleotide Aptamer Revenue by Company (2019-2024)
3.2.2 Global Oligonucleotide Aptamer Revenue Market Share by Company (2019-2024)
3.3 Global Oligonucleotide Aptamer Sale Price by Company
3.4 Key Manufacturers Oligonucleotide Aptamer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oligonucleotide Aptamer Product Location Distribution
3.4.2 Players Oligonucleotide Aptamer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Oligonucleotide Aptamer by Geographic Region
4.1 World Historic Oligonucleotide Aptamer Market Size by Geographic Region (2019-2024)
4.1.1 Global Oligonucleotide Aptamer Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oligonucleotide Aptamer Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oligonucleotide Aptamer Market Size by Country/Region (2019-2024)
4.2.1 Global Oligonucleotide Aptamer Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oligonucleotide Aptamer Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oligonucleotide Aptamer Sales Growth
4.4 APAC Oligonucleotide Aptamer Sales Growth
4.5 Europe Oligonucleotide Aptamer Sales Growth
4.6 Middle East & Africa Oligonucleotide Aptamer Sales Growth
5 Americas
5.1 Americas Oligonucleotide Aptamer Sales by Country
5.1.1 Americas Oligonucleotide Aptamer Sales by Country (2019-2024)
5.1.2 Americas Oligonucleotide Aptamer Revenue by Country (2019-2024)
5.2 Americas Oligonucleotide Aptamer Sales by Type (2019-2024)
5.3 Americas Oligonucleotide Aptamer Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide Aptamer Sales by Region
6.1.1 APAC Oligonucleotide Aptamer Sales by Region (2019-2024)
6.1.2 APAC Oligonucleotide Aptamer Revenue by Region (2019-2024)
6.2 APAC Oligonucleotide Aptamer Sales by Type (2019-2024)
6.3 APAC Oligonucleotide Aptamer Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oligonucleotide Aptamer by Country
7.1.1 Europe Oligonucleotide Aptamer Sales by Country (2019-2024)
7.1.2 Europe Oligonucleotide Aptamer Revenue by Country (2019-2024)
7.2 Europe Oligonucleotide Aptamer Sales by Type (2019-2024)
7.3 Europe Oligonucleotide Aptamer Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oligonucleotide Aptamer by Country
8.1.1 Middle East & Africa Oligonucleotide Aptamer Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oligonucleotide Aptamer Revenue by Country (2019-2024)
8.2 Middle East & Africa Oligonucleotide Aptamer Sales by Type (2019-2024)
8.3 Middle East & Africa Oligonucleotide Aptamer Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oligonucleotide Aptamer
10.3 Manufacturing Process Analysis of Oligonucleotide Aptamer
10.4 Industry Chain Structure of Oligonucleotide Aptamer
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oligonucleotide Aptamer Distributors
11.3 Oligonucleotide Aptamer Customer
12 World Forecast Review for Oligonucleotide Aptamer by Geographic Region
12.1 Global Oligonucleotide Aptamer Market Size Forecast by Region
12.1.1 Global Oligonucleotide Aptamer Forecast by Region (2025-2030)
12.1.2 Global Oligonucleotide Aptamer Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Oligonucleotide Aptamer Forecast by Type (2025-2030)
12.7 Global Oligonucleotide Aptamer Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Kaneka Corporation(Eurogentec)
13.1.1 Kaneka Corporation(Eurogentec) Company Information
13.1.2 Kaneka Corporation(Eurogentec) Oligonucleotide Aptamer Product Portfolios and Specifications
13.1.3 Kaneka Corporation(Eurogentec) Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Kaneka Corporation(Eurogentec) Main Business Overview
13.1.5 Kaneka Corporation(Eurogentec) Latest Developments
13.2 Danaher(Integrated DNA Technologies)
13.2.1 Danaher(Integrated DNA Technologies) Company Information
13.2.2 Danaher(Integrated DNA Technologies) Oligonucleotide Aptamer Product Portfolios and Specifications
13.2.3 Danaher(Integrated DNA Technologies) Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Danaher(Integrated DNA Technologies) Main Business Overview
13.2.5 Danaher(Integrated DNA Technologies) Latest Developments
13.3 Genescript
13.3.1 Genescript Company Information
13.3.2 Genescript Oligonucleotide Aptamer Product Portfolios and Specifications
13.3.3 Genescript Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Genescript Main Business Overview
13.3.5 Genescript Latest Developments
13.4 Azenta Life Sciences
13.4.1 Azenta Life Sciences Company Information
13.4.2 Azenta Life Sciences Oligonucleotide Aptamer Product Portfolios and Specifications
13.4.3 Azenta Life Sciences Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Azenta Life Sciences Main Business Overview
13.4.5 Azenta Life Sciences Latest Developments
13.5 Thermofischer
13.5.1 Thermofischer Company Information
13.5.2 Thermofischer Oligonucleotide Aptamer Product Portfolios and Specifications
13.5.3 Thermofischer Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Thermofischer Main Business Overview
13.5.5 Thermofischer Latest Developments
13.6 Eurofins Genomics
13.6.1 Eurofins Genomics Company Information
13.6.2 Eurofins Genomics Oligonucleotide Aptamer Product Portfolios and Specifications
13.6.3 Eurofins Genomics Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Eurofins Genomics Main Business Overview
13.6.5 Eurofins Genomics Latest Developments
13.7 Merck KGaA
13.7.1 Merck KGaA Company Information
13.7.2 Merck KGaA Oligonucleotide Aptamer Product Portfolios and Specifications
13.7.3 Merck KGaA Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Merck KGaA Main Business Overview
13.7.5 Merck KGaA Latest Developments
13.8 TriLink BioTechnologies
13.8.1 TriLink BioTechnologies Company Information
13.8.2 TriLink BioTechnologies Oligonucleotide Aptamer Product Portfolios and Specifications
13.8.3 TriLink BioTechnologies Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 TriLink BioTechnologies Main Business Overview
13.8.5 TriLink BioTechnologies Latest Developments
13.9 SBS Genetech
13.9.1 SBS Genetech Company Information
13.9.2 SBS Genetech Oligonucleotide Aptamer Product Portfolios and Specifications
13.9.3 SBS Genetech Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 SBS Genetech Main Business Overview
13.9.5 SBS Genetech Latest Developments
13.10 Bio-Synthesis Inc
13.10.1 Bio-Synthesis Inc Company Information
13.10.2 Bio-Synthesis Inc Oligonucleotide Aptamer Product Portfolios and Specifications
13.10.3 Bio-Synthesis Inc Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Bio-Synthesis Inc Main Business Overview
13.10.5 Bio-Synthesis Inc Latest Developments
13.11 Synbio Technologies
13.11.1 Synbio Technologies Company Information
13.11.2 Synbio Technologies Oligonucleotide Aptamer Product Portfolios and Specifications
13.11.3 Synbio Technologies Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Synbio Technologies Main Business Overview
13.11.5 Synbio Technologies Latest Developments
13.12 Oligo Factory
13.12.1 Oligo Factory Company Information
13.12.2 Oligo Factory Oligonucleotide Aptamer Product Portfolios and Specifications
13.12.3 Oligo Factory Oligonucleotide Aptamer Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Oligo Factory Main Business Overview
13.12.5 Oligo Factory Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂